SyVento and OncoArendi agreement

August 1, 2025

SyVento BioTech is proud to announce that, as of 31 July 2025, the company has officially obtained the Manufacturer/Importer Authorisation (MIA) — a vital regulatory certification that enables the manufacturing and importation of sterile and biological investigational medicinal products in full compliance with Good Manufacturing Practice (GMP) standards. This certification marks a major milestone for […]

July 18, 2025

We are proud to announce that SyVento BioTech will participate in BIO Asia–Taiwan 2025, one of the leading biotechnology and pharmaceutical events in the Asia-Pacific region. The exhibition and conference will take place from 23 to 27 July 2025 in Taipei. This international event brings together key innovators from across the life sciences sector. With […]

May 26, 2025

Join us from 16-19 June at Booth #949. As one of the world’s leading biotech events, BIO brings together thousands of innovators, investors, and industry leaders. For SyVento BioTech, it is a great opportunity to connect, collaborate, and showcase how our cutting-age solutions support development and delivery of next-generation mRNA therapeutics and other innovative medicines. […]

May 16, 2025

We are excited to announce that SyVento BioTech will be participating in 𝗧𝗜𝗗𝗘𝗦 𝗨𝗦𝗔, the leading event dedicated to oligonucleotide and peptide therapeutics. Representing us at the event will be Dylan Zuckerman – Business Development Manager, who will be available to connect, collaborate, and share insights into our latest advancements. Our services are designed to […]

May 13, 2025

At SyVento BioTech, we are not just developing RNA-based therapies — we are helping shape the next generation of scientists who will revolutionize them! In collaboration with the Faculty of Biochemistry, Biophysics and Biotechnology at Jagiellonian University, we have co-created the course “RNA – from Biology to Biotechnology” for Biotechnology students.This program goes beyond lectures. […]

April 28, 2025

We are excited to announce that SyVento BioTech will be participating in BIO Korea 2025, one of Asia’s premier biotechnology and pharmaceutical events, taking place 7–9 May in Seoul. Our company will be proudly represented by Eliza Milewicz, Member of the Supervisory Board, who will be engaging in one-on-one partnering meetings, exploring collaborative opportunities, and […]

April 9, 2025

We are excited to announce that SyVento BioTech will be attending the World Vaccine Congress in Washington, D.C. from April 22-24, 2025! This premier event brings together industry leaders to discuss groundbreaking advancements in vaccine development across infectious diseases, cancer immunotherapy, veterinary vaccines, and more. SyVento BioTech is committed to advancing vaccine technologies and biopharmaceutical […]

April 7, 2025

SyVento BioTech is proud to announce our participation in the 4th LNP Formulation & Process Development Summit in Boston– the premier global forum dedicated exclusively to Lipid Nanoparticle (LNP) innovation! As a company at the forefront of advanced drug delivery technologies, we cannot miss the opportunity to attend this significant event. SyVento BioTech specializes in […]

April 1, 2025

We are thrilled to share that SyVento BioTech will be a Silver Partner at CDMO Live this year. This is a fantastic event organized by Pharma Source that provides a unique platform to engage with industry expert, exchange insights, and present the innovative solutions shaping the future of science. We look forward to showcasing our […]